Optinose Inc (OPTN)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SERVICES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Peter K. Miller
Employees:
190
1020 STONY HILL ROAD, SUITE 300, YARDLEY, PA 19067
267-364-3500

OptiNose, Inc. focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. Onzetra Xsail, a powder EDS device, is in Phase IIIb clinical trial.

Data derived from most recent annual or quarterly report
Market Cap 134.668 Million Shares Outstanding112.223 Million Avg 30-day Volume 221.416 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.08
Price to Revenue1.9079 Debt to Equity-1.8575 EBITDA-25.987 Million
Price to Book Value0.0 Operating Margin-52.186 Enterprise Value195.895 Million
Current Ratio0.631 EPS Growth0.547 Quick Ratio0.569
1 Yr BETA 0.6508 52-week High/Low 2.07 / 0.9 Profit Margin-64.1305
Operating Cash Flow Growth1.1819 Free Cash Flow to Firm (FCFF) TTM -26.374 Million Free Cash Flow to Equity (FCFE) TTM-26.479 Million
Altman Z-Score-9.6764

Are you looking for this stock instead?

View SEC Filings from OPTN instead.

View recent insider trading info

Optinose Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding OPTN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding OPTN

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-09-19 by MAHMOUD RAMY A
  • 4: filed on 2023-09-19 by MARINO MICHAEL F III
  • 4: filed on 2023-06-20 by MARINO MICHAEL F III
  • 4: filed on 2023-06-20 by MAHMOUD RAMY A
  • 4: filed on 2023-06-09 by BEDNARSKI ERIC
  • 4: filed on 2023-06-09 by DEMPSEY KYLE
  • 4: filed on 2023-06-09 by HEYMAN TOMAS J.
  • 4: filed on 2023-06-09 by OWEN CATHERINE E.
  • 4: filed on 2023-03-20 by MARINO MICHAEL F III
  • 4: filed on 2023-03-20 by MAHMOUD RAMY A

    • Events (8k)

  • 8-K: filed on 2023-11-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-07-27:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-13:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-04:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-17:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-28:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-07:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-31:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

  • 144: filed on 2023-08-18:

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    MARINO MICHAEL F III CHIEF LEGAL OFFICER & CORP SEC

    • Officer
    		 334,699 2023-09-15 6

    MAHMOUD RAMY A CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 1,212,963 2023-09-15 6

    HELTON SANDRA L

    • Director
    		 0 2023-06-08 1

    FLETCHER R JOHN

    • Director
    		 0 2023-06-08 1

    GROENHUYSEN WILHELMUS CM

    • Director
    		 0 2023-06-08 1

    HEYMAN TOMAS J.

    • Director
    		 0 2023-06-08 1

    OWEN CATHERINE E.

    • Director
    		 0 2023-06-08 1

    BEDNARSKI ERIC

    • Director
    		 0 2023-06-08 1

    DEMPSEY KYLE

    • Director
    		 0 2023-06-08 1

    AVISTA CAPITAL PARTNERS II GP, LLC

    AVISTA CAPITAL PARTNERS II, L.P.

    AVISTA CAPITAL PARTNERS (OFFSHORE) II, L.P.

    AVISTA CAPITAL PARTNERS (OFFSHORE) II-A, LP

    • 10% Owner
    		 82,037 2023-05-12 1

    KRICK ANTHONY J CHIEF ACCOUNTING OFFICER

    • Officer
    		 33,833 2023-03-08 1

    MILLER PETER K CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 957,797 2023-01-13 2

    MVM PARTNERS, LLC

    • 10% Owner
    		 14,605,263 2022-12-31 1

    CLAVELLI VICTOR M CHIEF COMMERCIAL OFFICER

    • Officer
    		 199,955 2022-12-15 1

    JANIS MICHELE ACTING CHIEF FINANCIAL OFFICER

    • Officer
    		 48,927 2022-12-15 1

    SPENCE PAUL JR. CHIEF COMMERCIAL OFFICER

    • Officer
    		 500,000 2022-12-15 2

    SCODARI JOSEPH C

    • Director
    		 32,000 2022-06-08 0

    GOLDAN KEITH A. CHIEF FINANCIAL OFFICER

    • Officer
    		 141,726 2022-03-16 0

    MVM PARTNERS LLP

    • 10% Owner
    		 12,500,000 2021-11-18 0

    DOYLE WILLIAM F

    • Director
    		 0 2020-06-10 0

    VENKATARAMAN SRIRAM

    • Director
    • 10% Owner
    		 0 2020-06-10 0

    O'NEIL ROBERT P

    • Director
    		 0 2020-06-10 0

    TAMAROFF JOSHUA ALEXANDER

    • Director
    		 0 2020-06-10 0

    GIBBS THOMAS EDWARD CHIEF COMMERCIAL OFFICER

    • Officer
    		 5,364 2019-06-28 0

    TKWD VENTURES LLC

    • 10% Owner
    		 No longer subject to file 2018-06-28 0

    WFD VENTURES LLC

    • 10% Owner
    		 No longer subject to file 2018-06-28 0

    PICKERING LARRY G

    • Director
    		 382,356 2018-02-05 0

    ENTREPRENEURS FUND LP

    ENTREPRENEURS FUND GENERAL PARTNER LTD

    BRADSHAW PAUL

    • 10% Owner
    		 No longer subject to file 2017-10-17 0

    WFD VENTURES LLC

    TKWD VENTURES LLC

    • 10% Owner
    		 3,013,139 2017-10-17 0

    BIERLY RICK

    • Director
    		 0 2017-10-12 0

    MASTRAPA PAUL CFO

    • Officer
    		 157,266 2007-01-04 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    OPTINOSE INC OPTN 2023-11-28 22:15:04 UTC 4.3415 0.9785 300000
    OPTINOSE INC OPTN 2023-11-28 21:45:03 UTC 4.3415 0.9785 300000
    OPTINOSE INC OPTN 2023-11-28 21:15:04 UTC 4.3415 0.9785 300000
    OPTINOSE INC OPTN 2023-11-28 20:45:04 UTC 4.3415 0.9785 300000
    OPTINOSE INC OPTN 2023-11-28 20:15:04 UTC 4.3415 0.9785 300000
    OPTINOSE INC OPTN 2023-11-28 19:45:03 UTC 4.3415 0.9785 300000
    OPTINOSE INC OPTN 2023-11-28 19:15:04 UTC 4.3415 0.9785 300000
    OPTINOSE INC OPTN 2023-11-28 18:45:03 UTC 4.3415 0.9785 300000
    OPTINOSE INC OPTN 2023-11-28 18:15:03 UTC 4.3415 0.9785 300000
    OPTINOSE INC OPTN 2023-11-28 17:45:04 UTC 4.3433 0.9767 300000
    OPTINOSE INC OPTN 2023-11-28 17:15:04 UTC 4.3433 0.9767 300000
    OPTINOSE INC OPTN 2023-11-28 16:45:04 UTC 4.3433 0.9767 250000
    OPTINOSE INC OPTN 2023-11-28 16:15:04 UTC 4.3433 0.9767 250000
    OPTINOSE INC OPTN 2023-11-28 15:45:03 UTC 4.3433 0.9767 250000
    OPTINOSE INC OPTN 2023-11-28 15:15:03 UTC 4.3433 0.9767 250000
    OPTINOSE INC OPTN 2023-11-28 14:45:04 UTC 4.3432 0.9768 250000
    OPTINOSE INC OPTN 2023-11-28 14:15:04 UTC 4.3432 0.9768 250000
    OPTINOSE INC OPTN 2023-11-28 13:45:04 UTC 4.3424 0.9776 250000
    OPTINOSE INC OPTN 2023-11-28 13:15:03 UTC 4.3424 0.9776 250000
    OPTINOSE INC OPTN 2023-11-28 12:45:04 UTC 4.3424 0.9776 250000

    Current Active Short Positions

    Get more info on our International short position coverage here

    Holder Issuer Net Short Position Position Date Origin
    AQR Funds- AQR Small Cap Relaxed Constraint Equity Fund OPTN -1275.0 shares, $-8925.0 2019-09-30 N-PORT
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund OPTN -1500.0 shares, $-1845.0 2023-09-30 N-PORT
    Point72 Asset Management, L.P. Optinose, Inc. 0.52% 2018-08-21 GERMANY

    Short Position History (International Only)

    Holder Net Short Position Position Date Origin
    Point72 Asset Management, L.P. Optinose, Inc. 1.24% 2018-05-16 GERMANY
    Point72 Asset Management, L.P. OPTINOSE INC 1.35% 2018-05-18 GERMANY
    Point72 Asset Management, L.P. Optinose, Inc. 1.57% 2018-06-01 GERMANY
    Point72 Asset Management, L.P. Optinose, Inc. 1.77% 2018-06-05 GERMANY
    Point72 Asset Management, L.P. Optinose, Inc. 1.53% 2018-06-27 GERMANY
    Point72 Asset Management, L.P. Optinose, Inc. 1.26% 2018-06-28 GERMANY
    Point72 Asset Management, L.P. Optinose, Inc. 0.81% 2018-08-14 GERMANY
    Point72 Asset Management, L.P. Optinose, Inc. 0.63% 2018-08-16 GERMANY

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments